Company / Profit Margin
Immunome Inc. Profit Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-3060.0%
FY2025
5-year range
-3060.0% / -263.2%
FY2023-FY2025
Trend
-301.6%
vs FY2024
Sector context
#137 of 145
Health Care
What the data says
Profit Margin changed -302% YoY in FY2025, a notable deviation from the 2-year average annual change of -246%.
Based on SEC 10-K filings.
-3060.0% in FY2025.
Declined from -263.2% to -3060.0% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 145This company -3060.0% Sector average -792.7%
▼
-286.0% below sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 301.6% year-over-year.
- Currently 2267.3pp below the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3060.0% | -301.6% |
| FY2024 | -761.9% | -189.5% |
| FY2023 | -263.2% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026